Cloxacillin Pediatric Dosing
For methicillin-susceptible staphylococcal infections in children, cloxacillin should be dosed at 150-200 mg/kg/day divided every 6-8 hours for parenteral therapy, with oral dosing typically at 50-100 mg/kg/day divided into 3-4 doses.
Parenteral (IV) Dosing
For serious infections requiring intravenous therapy:
- Standard dose: 150-200 mg/kg/day divided every 6-8 hours 1, 2, 1, 2, 1, 2, 1
- This dosing is specifically recommended for methicillin-susceptible Staphylococcus aureus (MSSA) infections including community-acquired pneumonia
- Maximum daily dose: Should not exceed adult dosing equivalents 1
Clinical Context
The guidelines position cloxacillin (and other semisynthetic penicillins like oxacillin) as preferred first-line agents for MSSA infections, with alternatives being cefazolin (150 mg/kg/day every 8 hours), clindamycin (40 mg/kg/day every 6-8 hours), or vancomycin (40-60 mg/kg/day every 6-8 hours) 1, 2.
Oral Dosing
For step-down therapy or mild infections:
- While the provided guidelines do not specify oral cloxacillin dosing explicitly, they recommend oral cephalexin (75-100 mg/kg/day in 3-4 doses) as the preferred oral agent for MSSA 1, 2
- Recent evidence suggests oral cloxacillin is effective for uncomplicated bacterial infections in children 3
- Typical oral dosing range: 50-100 mg/kg/day divided into 3-4 doses (based on general pediatric practice)
Dosing Interval Considerations
The every 6-8 hour interval is pharmacologically important:
- Cloxacillin is a time-dependent antibiotic requiring adequate time above MIC (T>MIC) 4
- For optimal efficacy, maintain T>MIC for at least 40-50% of the dosing interval 4
- Do not extend dosing intervals beyond 8 hours to maintain therapeutic concentrations
Special Populations
Neonates
The provided guidelines specifically address children older than 3 months 1, 2. For neonates, dosing requires separate consideration based on:
- Gestational age
- Postnatal age
- Renal function maturity
- Consult neonatal-specific dosing references as pharmacokinetics differ substantially from older infants 5
Renal Impairment
- Dose adjustment is critical in patients with reduced renal function 6, 7
- Recent evidence shows that patients with preserved renal function (GFR >90 mL/min/1.73 m²) may require higher doses, while those with impaired function need reduction 6, 7
- Monitor drug levels when available, targeting steady-state concentrations of 20-50 mg/L 6
Obesity
- Weight-based dosing may result in subtherapeutic levels in larger children 7, 8
- Children >100 kg are at risk for inadequate concentrations with standard mg/kg dosing 7
- Consider using actual body weight for dosing calculations but monitor clinical response closely
- Do not arbitrarily cap doses at "adult maximum" if weight-based calculations exceed this, as larger children may be systematically underdosed 8
Common Pitfalls
Underdosing larger/older children: Evidence shows a concerning trend where children >60 kg receive declining mg/kg doses, often falling below therapeutic targets 8. Calculate the full weight-based dose even if it exceeds typical adult doses.
Inadequate dosing frequency: Extending intervals beyond 8 hours risks subtherapeutic concentrations due to cloxacillin's short half-life 4.
Ignoring renal function: Both extremes matter—preserved renal function may require higher doses, while impairment necessitates reduction 6, 7.
Assuming oral and IV equivalence: Oral bioavailability differs; do not simply convert IV to oral doses without considering absorption.
Using broad-spectrum agents unnecessarily: Cloxacillin's narrow spectrum is advantageous for confirmed MSSA infections, reducing selection pressure for resistance 4. Recent data confirms it is as effective as amoxicillin-clavulanate for appropriate indications 3.